Drug-related Halitosis: A Systematic Review

被引:5
作者
Mortazavi, Hamed [1 ]
Nobar, Behrad Rahbani [2 ]
Shafiei, Shervin [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Dent, Dept Oral Med, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Sch Dent, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Dent, Dept Oral & Maxillofacial Surg, Tehran, Iran
关键词
adverse drug events; adverse drug reactions; drug side effects; extra-oral halitosis; halitosis; TOPICAL DICLOFENAC SOLUTION; PHASE-I; DIMETHYL-SULFOXIDE; DOUBLE-BLIND; PRIMARY OSTEOARTHRITIS; CYSTINOSIS PATIENTS; RELEASE CYSTEAMINE; EFFICACY; INHIBITOR; MALODOR;
D O I
10.3290/j.ohpd.a44679
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: Halitosis is an unpleasant breath odor which can be bothersome to individuals. Extra-oral halitosis is a type of halitosis caused by systemic conditions, bloodborne diseases, or pharmaceutical therapy. It is not related to local factors in the oral cavity. This systematic review aimed to identify the medications that can cause extra-oral halitosis. Materials and Methods: This study was conducted in accordance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA). We searched online databases and also included hand searching to find relevant articles. Two authors independently performed the screening, data extraction and quality assessment of the included articles using the Cochrane Collaboration assessment tool. Results: Thirty-four studies met the eligibility criteria. The medications which can cause extra-oral halitosis were categorised into 10 groups: acid reducers, aminothiols, anticholinergics, antidepressants, antifungals, antihistamines and steroids, antispasmodics, chemotherapeutic agents, dietary supplements, and organosulfur substances. Conclusion: Pharmaceutical therapy is a potential source of extra-oral halitosis. This finding can help clinicians detect the probable causes of halitosis. Further studies are needed to definitely determine the role of various medications in causing extra-oral halitosis.
引用
收藏
页码:399 / 407
页数:9
相关论文
共 56 条
  • [1] Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study
    Ahlenstiel-Grunow, Thurid
    Kanzelmeyer, Nele K.
    Froede, Kerstin
    Kreuzer, Martin
    Drube, Jens
    Lerch, Christian
    Pape, Lars
    [J]. PEDIATRIC NEPHROLOGY, 2017, 32 (01) : 91 - 97
  • [2] High-Dose Sodium Selenite Can Induce Apoptosis of Lymphoma Cells in Adult Patients with Non-Hodgkin's Lymphoma
    Asfour, Inas A.
    El-Tehewi, Maha M.
    Ahmed, Manal H.
    Abdel-Sattar, Mey A.
    Moustafa, Nevine N.
    Hegab, Hany M.
    Fathey, Omar M.
    [J]. BIOLOGICAL TRACE ELEMENT RESEARCH, 2009, 127 (03) : 200 - 210
  • [3] Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]
    Baer, PA
    Thomas, LM
    Shainhouse, Z
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2005, 6 (1)
  • [4] A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers
    Baker, A. F.
    Adab, K. N.
    Raghunand, N.
    Chow, H. H. S.
    Stratton, S. P.
    Squire, S. W.
    Boice, M.
    Pestano, L. A.
    Kirkpatrick, D. L.
    Dragovich, T.
    [J]. INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 631 - 641
  • [5] Bakhtiari Sedigheh, 2018, Clujul Med, V91, P27, DOI 10.15386/cjmed-748
  • [6] Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA
    Barrou, B
    Benoît, GR
    Ouldkaci, M
    Cussenot, O
    Salcedo, M
    Agrawal, S
    Massicard, SV
    Bercovici, N
    Ericson, ML
    Thiounn, N
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (05) : 453 - 460
  • [7] EFFECTS OF NEW FISH-OIL DERIVATIVE AN FATTY-ACID PHOSPHOLIPID-MEMBRANE PATTERN IN A GROUP OF CROHNS-DISEASE PATIENTS
    BELLUZZI, A
    BRIGNOLA, C
    CAMPIERI, M
    CAMPORESI, EP
    GIONCHETTI, P
    RIZZELLO, F
    BELLOLI, C
    DESIMONE, G
    BOSCHI, S
    MIGLIOLI, M
    BARBARA, L
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (12) : 2589 - 2594
  • [8] The origin of halitosis in cystinotic patients due to eysteamine treatment
    Besouw, Martine
    Blom, Henk
    Tangerman, Albert
    de Graaf-Hess, Adriana
    Levtchenko, Elena
    [J]. MOLECULAR GENETICS AND METABOLISM, 2007, 91 (03) : 228 - 233
  • [9] Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate
    Besouw, Martine
    Tangerman, Albert
    Cornelissen, Elisabeth
    Rioux, Patrice
    Levtchenko, Elena
    [J]. MOLECULAR GENETICS AND METABOLISM, 2012, 107 (1-2) : 234 - 236
  • [10] Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial
    Bookman, AAM
    Williams, KSA
    Shainhouse, JZ
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (04) : 333 - 338